Embedded Files
Are you Making the Most of How R&D Tax Relief Works with Other UK Innovation Incentives?
The UK offers a rich landscape of incentives for businesses that innovate to help them invest and grow. For companies undertaking research and development (R&D), the revised R&D Expenditure Credit – RDEC will often be the cornerstone of support. However, it rarely exists in isolation. Other schemes such as the Patent Box, Innovate UK grants, and investment incentives like the Enterprise Investment Scheme (EIS) and Seed Enterprise Investment Scheme (SEIS) can also play key roles.
Understanding how these schemes interact — and how to combine them effectively — can significantly enhance the overall benefit to an innovative business.
R&D Tax Relief and Tax Credit : The Foundation of Innovation Support
R&D tax relief rewards companies that seek to achieve scientific or technological advances through their projects. It allows businesses to claim a proportion of qualifying R&D expenditure back as a Corporation Tax reduction or payable credit.
From April 2024, the merged R&D scheme brought together aspects of the SME and RDEC regimes, creating a simpler and more consistent framework. The good news for Small & Medium Enterprise (SME) companies is that receiving an Innovate UK grant no longer automatically reduces the R&D tax relief value, as was the case under earlier rules. This change gives more flexibility to combine grant funding and tax incentives for the same innovation programme — an important boost for growth-stage companies managing multiple funding streams.
R&D Tax Relief and the Patent Box: Linking Innovation to IP Income
The Patent Box complements R&D tax relief by rewarding successful commercialisation of innovation. It allows companies to apply a reduced 10% rate of Corporation Tax on profits derived from patented inventions and other qualifying intellectual property.
Due to the increase in standard rate corporation tax (the main rate of UK Corporation Tax increased from 19% to 25% on 1 April 2023), even though the Patent Box rate remained at 10%, the tax saving for companies subject to the 25% rate surged. Before April 2023: 19% vs. 10% gives a 9% tax saving, after April 2023: 25% vs 10% gives a 15% tax saving.
These two incentives work best when planned together:
R&D tax relief supports the development of new or improved products, processes, or technologies.
Patent Box reduces the tax on profits generated by the resulting intellectual property.
To maximise benefit, companies should:
Identify potentially patentable outcomes early in the R&D process.
Keep detailed records linking R&D expenditure to the patents and related revenues.
Consider patent protection strategies in tandem with R&D planning, ensuring qualifying IP ownership resides within the UK entity.
Used strategically, the R&D tax relief and Patent Box can significantly reduce the effective tax rate across the entire innovation lifecycle — from initial research through to commercial success.
Innovate UK Grants and R&D Tax Relief: A More Flexible Relationship
Innovate UK grants and other streams of grant funding, provide essential funding for high-risk or early-stage innovation projects. Historically, companies receiving grants often found their R&D tax claims restricted, particularly where funding was classified as “notified state aid”.
Under the new merged R&D scheme, the interaction has become much more favourable. Grant funding no longer automatically disqualifies related costs from R&D relief. Instead, the tax treatment depends on how the funding is structured and which specific costs it covers.
To optimise both:
Clearly separate project costs funded by grants from those covered by company resources.
Maintain transparent records showing how each cost category is funded.
Plan submissions to Innovate UK and HMRC for R&D relief to help manage cashflows.
This approach enables businesses to access both upfront cash support from grants and longer-term benefits from R&D tax relief — improving liquidity and sustaining innovation momentum.
EIS and SEIS: Attracting Investment to Fund Innovation
Private investment is another critical part of the innovation ecosystem, and the Enterprise Investment Scheme (EIS) and Seed Enterprise Investment Scheme (SEIS) are designed to encourage investors to back early-stage UK companies.
EIS supports growth-stage businesses by offering investors up to 30% income tax relief on investments of up to £1 million per year, with potential capital gains tax exemptions after holding shares for at least three years.
SEIS, aimed at very early-stage businesses, became more generous from 6 April 2023. Companies can now raise up to £250,000 (up from £150,000), investors can claim relief on up to £200,000 per year, and qualifying companies may be up to three years old (previously two).
While EIS and SEIS operate primarily on the investment side, they align closely with R&D tax relief in practice:
R&D tax relief boosts cash flow and reduces risk, making a company more appealing to investors.
EIS and SEIS investment can finance the R&D that later forms the basis of tax claims.
The key is compliance — ensuring that the structure of any investment and use of funds remains consistent with EIS/SEIS eligibility criteria and HMRC’s “risk-to-capital” condition.
Common Pitfalls and How to Avoid Them
The main pitfalls include poor application of the rules and guidelines, mismatched timings, incomplete documentation and assuming all grant or investor-funded work qualifies as R&D.
To avoid these issues:
Integrate tax and funding strategies early in the innovation planning process.
Keep detailed, contemporaneous project records.
Review how grant, investor and commercial income streams interact.
Consider seeking professional advice to ensure compliance is always achieved.
Maximising Total Benefit
Used together, the UK’s innovation incentives can provide a powerful financial advantage:
R&D tax relief delivers ongoing cash flow support.
Patent Box rewards commercial success.
Innovate UK grants provide upfront funding.
EIS and SEIS attract vital private capital to fuel growth.
A joined-up approach can turn R&D expenditure into a long-term value driver, improving both short-term liquidity and post-commercialisation profitability. As the government continues to simplify and enhance these incentives, innovative UK companies are better placed than ever to leverage them in combination — accelerating growth and rewarding genuine innovation.
Read more R&D Tax Credit Articles and News
Get insights into all the key aspects of claiming R&D tax relief and RDEC.
Page updated
Google Sites
Report abuse